Results 101 to 110 of about 9,856 (174)

Immune correlates of HIV-1 rebound during broadly neutralizing antibody treatment in young children. [PDF]

J Clin Invest
Niesar A, Lancien M, Hong S, Naasz C, Ajibola G, Maswabi K, Sakoi-Mosetlhi M, Batlang O, Moyo S, Mohammed T, Maphorisa C, Carrere L, Roseto I, Hartana CA, Tan TS, Gao C, Parsons E, Hua R, Pretorius Holme M, Lockman S, Powis KM, Carrington M, Makhema J, Yu XG, Kuritzkes DR, Shapiro RL, Lichterfeld M.   +26 more
europepmc   +1 more source

Editorial: NK cells in transplantation. [PDF]

Front Immunol
McCurdy SR, Azar H, Beldi-Ferchiou A.
europepmc   +1 more source

Cytotoxic lymphocyte heterogeneity in glioblastoma: insights from single-cell and spatial multiomics toward precision immunotherapeutic reprogramming. [PDF]

Front Immunol
Dong W, Li Y, Wu Z, Fu Q, Zhao J, Wang B, Yao J, Lu C, Tong M.   +8 more
europepmc   +1 more source

NKG2A-mediated immune modulation of natural killer cells by Staphylococcus aureus. [PDF]

J Immunol
Davies K, Rizek AM, Edkins S, Kollnberger S, Wang ECY, Eberl M, Underwood J, McLaren JE.   +7 more
europepmc   +1 more source

Single-Cell Transcriptome Profiling Reveals the Immune Dysregulation Characteristics of Mice Infected With Brucella abortus. [PDF]

J Infect Dis
Zhang G, Shen Q, Ye J, Feng Y, Boireau P, Fan X, Lv L, Li Y, Xu X, Cha H, Shen C, Zhang Y, Peng X, Jiang H, Ding J.   +14 more
europepmc   +1 more source

Chemotherapy-induced senescent nasopharyngeal carcinoma cells suppress NK cell-mediated antitumor immunity by upregulating EBI3 via mtDNA-cGAS-STING pathway. [PDF]

Cell Commun Signal
Liang L, Liu S, Li Y, Zeng F, He Q, Wang Z, Deng J, Zhou Y.   +7 more
europepmc   +1 more source

Imaging mass cytometry of the immune microenvironment in alveolar echinococcosis. [PDF]

Front Cell Infect Microbiol
Ma Y, Zhang Y, Zhang T, Zhang L, Wang Z, Yang Z, Guo X, Han J, Hou J, Tian M, Huang D, Wang H, Fan H.   +12 more
europepmc   +1 more source

Functional recovery of NK cells after T-cell replete haploidentical HSCT: delayed licensing and poor anti-acute myeloid leukemia activity. [PDF]

Blood Adv
Jullien M, Ferron E, Willem C, David G, Legrand N, Duquesne A, Bouzy S, Bastien M, Garnier A, Guillaume T, Le Bourgeois A, Vantyghem S, Peterlin P, Gagne K, Chevallier P, Retière C.   +15 more
europepmc   +1 more source

CD40L and IL-4 lymph node-associated signals protect B cells from rituximab-induced ADCC via KIR and NKG2A. [PDF]

Clin Exp Immunol
Graham LV, Foxall RB, Ashton-Key M, Khakoo SI, Sayegh S, Leandro M, Reddy VR, Cragg MS, Blunt MD.   +8 more
europepmc   +1 more source

Nonclassical MHC-I Molecules: Emerging Therapeutic Targets in Next-Generation Immunotherapy. [PDF]

MedComm (2020)
He W, McMichael AJ.
europepmc   +1 more source